APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ranibizumab Drugs and Biosimilars

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ranibizumab Drugs and Biosimilars Industry Growth and Trends Forecast to 2032

27 December 202578 pages

Choose your research edition.

Industry ResearchRanibizumab Drugs and Biosimilars Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Ranibizumab Drugs and Biosimilars Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Ranibizumab Drugs and Biosimilars Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ranibizumab Drugs and Biosimilars Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Ranibizumab Drugs and Biosimilars Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Ranibizumab Drugs and Biosimilars market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ranibizumab Drugs and Biosimilars is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ranibizumab Drugs and Biosimilars is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ranibizumab Drugs and Biosimilars is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ranibizumab Drugs and Biosimilars include Coherus Biosciences, Roche and Samsung Bioepis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ranibizumab Drugs and Biosimilars market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ranibizumab Drugs and Biosimilars market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ranibizumab Drugs and Biosimilars market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ranibizumab Drugs and Biosimilars.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ranibizumab Drugs and Biosimilars market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ranibizumab Drugs and Biosimilars Market by Company

Coherus Biosciences

Roche

Samsung Bioepis

Ranibizumab Drugs and Biosimilars Segment by Type

0.5mg per Vial

2mg per Vial

Ranibizumab Drugs and Biosimilars Segment by Application

Cancer

Degenerative Eye Diseases

Other

Ranibizumab Drugs and Biosimilars Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ranibizumab Drugs and Biosimilars market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ranibizumab Drugs and Biosimilars and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ranibizumab Drugs and Biosimilars.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ranibizumab Drugs and Biosimilars manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ranibizumab Drugs and Biosimilars in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 0.5mg per Vial Table 2. Major Company of 2mg per Vial Table 3. Global Ranibizumab Drugs and Biosimilars Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Ranibizumab Drugs and Biosimilars Sales by Type (2021-2026) & (K Units) Table 5. Global Ranibizumab Drugs and Biosimilars Sales Market Share in Volume by Type (2021-2026) Table 6. Global Ranibizumab Drugs and Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 7. Global Ranibizumab Drugs and Biosimilars Sales Market Share in Value by Type (2021-2026) Table 8. Global Ranibizumab Drugs and Biosimilars Price by Type (2021-2026) & (US$/Unit) Table 9. Global Ranibizumab Drugs and Biosimilars Sales by Type (2027-2032) & (K Units) Table 10. Global Ranibizumab Drugs and Biosimilars Sales Market Share in Volume by Type (2027-2032) Table 11. Global Ranibizumab Drugs and Biosimilars Sales by Type (2027-2032) & (US$ Million) Table 12. Global Ranibizumab Drugs and Biosimilars Sales Market Share in Value by Type (2027-2032) Table 13. Global Ranibizumab Drugs and Biosimilars Price by Type (2027-2032) & (US$/Unit) Table 14. North America Ranibizumab Drugs and Biosimilars Sales by Type (2021-2026) & (K Units) Table 15. North America Ranibizumab Drugs and Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Ranibizumab Drugs and Biosimilars Sales by Type (2021-2026) & (K Units) Table 17. Europe Ranibizumab Drugs and Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Ranibizumab Drugs and Biosimilars Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Ranibizumab Drugs and Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Ranibizumab Drugs and Biosimilars Sales by Type (2021-2026) & (K Units) Table 21. Latin America Ranibizumab Drugs and Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Ranibizumab Drugs and Biosimilars Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Ranibizumab Drugs and Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 24. Ranibizumab Drugs and Biosimilars Industry Trends Table 25. Ranibizumab Drugs and Biosimilars Industry Drivers Table 26. Ranibizumab Drugs and Biosimilars Industry Opportunities and Challenges Table 27. Ranibizumab Drugs and Biosimilars Industry Restraints Table 28. Global Ranibizumab Drugs and Biosimilars Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Ranibizumab Drugs and Biosimilars Revenue Market Share by Company (2021-2026) Table 30. Global Ranibizumab Drugs and Biosimilars Sales by Company (2021-2026) & (K Units) Table 31. Global Ranibizumab Drugs and Biosimilars Sales Share by Company (2021-2026) Table 32. Global Ranibizumab Drugs and Biosimilars Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Ranibizumab Drugs and Biosimilars Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Ranibizumab Drugs and Biosimilars Major Company Production Sites and Headquarters Table 35. Global Ranibizumab Drugs and Biosimilars Company, Product Type & Application Table 36. Global Ranibizumab Drugs and Biosimilars Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Ranibizumab Drugs and Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Ranibizumab Drugs and Biosimilars Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Ranibizumab Drugs and Biosimilars Sales by Region (2021-2026) & (K Units) Table 41. Global Ranibizumab Drugs and Biosimilars Sales Market Share in Volume by Region (2021-2026) Table 42. Global Ranibizumab Drugs and Biosimilars Sales by Region (2021-2026) & (US$ Million) Table 43. Global Ranibizumab Drugs and Biosimilars Sales Market Share in Value by Region (2021-2026) Table 44. Global Ranibizumab Drugs and Biosimilars Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Ranibizumab Drugs and Biosimilars Sales by Region (2027-2032) & (K Units) Table 46. Global Ranibizumab Drugs and Biosimilars Sales Market Share in Volume by Region (2027-2032) Table 47. Global Ranibizumab Drugs and Biosimilars Sales by Region (2027-2032) & (US$ Million) Table 48. Global Ranibizumab Drugs and Biosimilars Sales Market Share in Value by Region (2027-2032) Table 49. Global Ranibizumab Drugs and Biosimilars Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Ranibizumab Drugs and Biosimilars Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Ranibizumab Drugs and Biosimilars Sales by Application (2021-2026) & (K Units) Table 52. Global Ranibizumab Drugs and Biosimilars Sales Market Share in Volume by Application (2021-2026) Table 53. Global Ranibizumab Drugs and Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 54. Global Ranibizumab Drugs and Biosimilars Sales Market Share in Value by Application (2021-2026) Table 55. Global Ranibizumab Drugs and Biosimilars Price by Application (2021-2026) & (US$/Unit) Table 56. Global Ranibizumab Drugs and Biosimilars Sales by Application (2027-2032) & (K Units) Table 57. Global Ranibizumab Drugs and Biosimilars Sales Market Share in Volume by Application (2027-2032) Table 58. Global Ranibizumab Drugs and Biosimilars Sales by Application (2027-2032) & (US$ Million) Table 59. Global Ranibizumab Drugs and Biosimilars Sales Market Share in Value by Application (2027-2032) Table 60. Global Ranibizumab Drugs and Biosimilars Price by Application (2027-2032) & (US$/Unit) Table 61. North America Ranibizumab Drugs and Biosimilars Sales by Application (2021-2026) & (K Units) Table 62. North America Ranibizumab Drugs and Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Ranibizumab Drugs and Biosimilars Sales by Application (2021-2026) & (K Units) Table 64. Europe Ranibizumab Drugs and Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Ranibizumab Drugs and Biosimilars Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Ranibizumab Drugs and Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Ranibizumab Drugs and Biosimilars Sales by Application (2021-2026) & (K Units) Table 68. Latin America Ranibizumab Drugs and Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Ranibizumab Drugs and Biosimilars Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Ranibizumab Drugs and Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 71. Coherus Biosciences Company Information Table 72. Coherus Biosciences Business Overview Table 73. Coherus Biosciences Ranibizumab Drugs and Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Coherus Biosciences Ranibizumab Drugs and Biosimilars Product Portfolio Table 75. Coherus Biosciences Recent Development Table 76. Roche Company Information Table 77. Roche Business Overview Table 78. Roche Ranibizumab Drugs and Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Roche Ranibizumab Drugs and Biosimilars Product Portfolio Table 80. Roche Recent Development Table 81. Samsung Bioepis Company Information Table 82. Samsung Bioepis Business Overview Table 83. Samsung Bioepis Ranibizumab Drugs and Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Samsung Bioepis Ranibizumab Drugs and Biosimilars Product Portfolio Table 85. Samsung Bioepis Recent Development Table 86. North America Ranibizumab Drugs and Biosimilars Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 87. North America Ranibizumab Drugs and Biosimilars Sales by Country (2021-2026) & (K Units) Table 88. North America Ranibizumab Drugs and Biosimilars Sales Market Share by Country (2021-2026) Table 89. North America Ranibizumab Drugs and Biosimilars Sales Forecast by Country (2027-2032) & (K Units) Table 90. North America Ranibizumab Drugs and Biosimilars Sales Market Share Forecast by Country (2027-2032) Table 91. North America Ranibizumab Drugs and Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America Ranibizumab Drugs and Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 93. North America Ranibizumab Drugs and Biosimilars Market Share by Country (2021-2026) Table 94. North America Ranibizumab Drugs and Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America Ranibizumab Drugs and Biosimilars Market Share Forecast by Country (2027-2032) Table 96. Europe Ranibizumab Drugs and Biosimilars Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. Europe Ranibizumab Drugs and Biosimilars Sales by Country (2021-2026) & (K Units) Table 98. Europe Ranibizumab Drugs and Biosimilars Sales Market Share by Country (2021-2026) Table 99. Europe Ranibizumab Drugs and Biosimilars Sales Forecast by Country (2027-2032) & (K Units) Table 100. Europe Ranibizumab Drugs and Biosimilars Sales Market Share Forecast by Country (2027-2032) Table 101. Europe Ranibizumab Drugs and Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe Ranibizumab Drugs and Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe Ranibizumab Drugs and Biosimilars Market Share by Country (2021-2026) Table 104. Europe Ranibizumab Drugs and Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe Ranibizumab Drugs and Biosimilars Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Ranibizumab Drugs and Biosimilars Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Ranibizumab Drugs and Biosimilars Sales by Country (2021-2026) & (K Units) Table 108. Asia-Pacific Ranibizumab Drugs and Biosimilars Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific Ranibizumab Drugs and Biosimilars Sales Forecast by Country (2027-2032) & (K Units) Table 110. Asia-Pacific Ranibizumab Drugs and Biosimilars Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Ranibizumab Drugs and Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Ranibizumab Drugs and Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific Ranibizumab Drugs and Biosimilars Market Share by Country (2021-2026) Table 114. Asia-Pacific Ranibizumab Drugs and Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific Ranibizumab Drugs and Biosimilars Market Share Forecast by Country (2027-2032) Table 116. Latin America Ranibizumab Drugs and Biosimilars Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Latin America Ranibizumab Drugs and Biosimilars Sales by Country (2021-2026) & (K Units) Table 118. Latin America Ranibizumab Drugs and Biosimilars Sales Market Share by Country (2021-2026) Table 119. Latin America Ranibizumab Drugs and Biosimilars Sales Forecast by Country (2027-2032) & (K Units) Table 120. Latin America Ranibizumab Drugs and Biosimilars Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America Ranibizumab Drugs and Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America Ranibizumab Drugs and Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America Ranibizumab Drugs and Biosimilars Market Share by Country (2021-2026) Table 124. Latin America Ranibizumab Drugs and Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America Ranibizumab Drugs and Biosimilars Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Ranibizumab Drugs and Biosimilars Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Ranibizumab Drugs and Biosimilars Sales by Country (2021-2026) & (K Units) Table 128. Middle East and Africa Ranibizumab Drugs and Biosimilars Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa Ranibizumab Drugs and Biosimilars Sales Forecast by Country (2027-2032) & (K Units) Table 130. Middle East and Africa Ranibizumab Drugs and Biosimilars Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Ranibizumab Drugs and Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Ranibizumab Drugs and Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa Ranibizumab Drugs and Biosimilars Market Share by Country (2021-2026) Table 134. Middle East and Africa Ranibizumab Drugs and Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa Ranibizumab Drugs and Biosimilars Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Ranibizumab Drugs and Biosimilars Distributors List Table 139. Ranibizumab Drugs and Biosimilars Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Ranibizumab Drugs and Biosimilars Image Figure 2. Global Ranibizumab Drugs and Biosimilars Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ranibizumab Drugs and Biosimilars Market Size (2021-2032) & (US$ Million) Figure 4. Global Ranibizumab Drugs and Biosimilars Sales (2021-2032) & (K Units) Figure 5. 0.5mg per Vial Image Figure 6. Global 0.5mg per Vial Sales YoY Growth (2021-2032) & (K Units) Figure 7. 2mg per Vial Image Figure 8. Global 2mg per Vial Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Ranibizumab Drugs and Biosimilars Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Ranibizumab Drugs and Biosimilars Market Share by Type 2025 VS 2032 Figure 11. North America Ranibizumab Drugs and Biosimilars Sales Market Share in Volume by Type in 2025 Figure 12. North America Ranibizumab Drugs and Biosimilars Sales Market Share in Value by Type in 2025 Figure 13. Europe Ranibizumab Drugs and Biosimilars Sales Market Share in Volume by Type in 2025 Figure 14. Europe Ranibizumab Drugs and Biosimilars Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Ranibizumab Drugs and Biosimilars Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Ranibizumab Drugs and Biosimilars Sales Market Share in Value by Type in 2025 Figure 17. Latin America Ranibizumab Drugs and Biosimilars Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Ranibizumab Drugs and Biosimilars Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Ranibizumab Drugs and Biosimilars Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Ranibizumab Drugs and Biosimilars Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Ranibizumab Drugs and Biosimilars Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Cancer Image Figure 24. Global Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 25. Degenerative Eye Diseases Image Figure 26. Global Degenerative Eye Diseases Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Ranibizumab Drugs and Biosimilars Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Ranibizumab Drugs and Biosimilars Market Share by Application 2025 VS 2032 Figure 31. North America Ranibizumab Drugs and Biosimilars Sales Market Share in Volume by Application in 2025 Figure 32. North America Ranibizumab Drugs and Biosimilars Sales Market Share in Value by Application in 2025 Figure 33. Europe Ranibizumab Drugs and Biosimilars Sales Market Share in Volume by Application in 2025 Figure 34. Europe Ranibizumab Drugs and Biosimilars Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Ranibizumab Drugs and Biosimilars Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Ranibizumab Drugs and Biosimilars Sales Market Share in Value by Application in 2025 Figure 37. Latin America Ranibizumab Drugs and Biosimilars Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Ranibizumab Drugs and Biosimilars Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Ranibizumab Drugs and Biosimilars Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Ranibizumab Drugs and Biosimilars Sales Market Share in Value by Application in 2025 Figure 41. North America Ranibizumab Drugs and Biosimilars Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Ranibizumab Drugs and Biosimilars Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Ranibizumab Drugs and Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Ranibizumab Drugs and Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Ranibizumab Drugs and Biosimilars Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Ranibizumab Drugs and Biosimilars Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Ranibizumab Drugs and Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Ranibizumab Drugs and Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Ranibizumab Drugs and Biosimilars Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Ranibizumab Drugs and Biosimilars Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Ranibizumab Drugs and Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Ranibizumab Drugs and Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Ranibizumab Drugs and Biosimilars Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Ranibizumab Drugs and Biosimilars Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Ranibizumab Drugs and Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Ranibizumab Drugs and Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Ranibizumab Drugs and Biosimilars Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Ranibizumab Drugs and Biosimilars Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Ranibizumab Drugs and Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Ranibizumab Drugs and Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Ranibizumab Drugs and Biosimilars Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Ranibizumab Drugs and Biosimilars Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5mg per Vial
  • 2mg per Vial
Applications
  • Cancer
  • Degenerative Eye Diseases
  • Other
Companies covered
  • Coherus Biosciences
  • Roche
  • Samsung Bioepis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ranibizumab Drugs and Biosimilars Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ranibizumab Drugs and Biosimilars Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ranibizumab Drugs and Biosimilars Market by Type
  6. 1.3.1 0.5mg per Vial
  7. 1.3.2 2mg per Vial
  8. 1.4 Global Ranibizumab Drugs and Biosimilars Market Size by Type
  9. 1.4.1 Global Ranibizumab Drugs and Biosimilars Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Ranibizumab Drugs and Biosimilars Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Ranibizumab Drugs and Biosimilars Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Ranibizumab Drugs and Biosimilars Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Ranibizumab Drugs and Biosimilars Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Ranibizumab Drugs and Biosimilars Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Ranibizumab Drugs and Biosimilars Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Ranibizumab Drugs and Biosimilars Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ranibizumab Drugs and Biosimilars Industry Trends
  2. 2.2 Ranibizumab Drugs and Biosimilars Industry Drivers
  3. 2.3 Ranibizumab Drugs and Biosimilars Industry Opportunities and Challenges
  4. 2.4 Ranibizumab Drugs and Biosimilars Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ranibizumab Drugs and Biosimilars Revenue (2021-2026)
  2. 3.2 Global Top Players by Ranibizumab Drugs and Biosimilars Sales (2021-2026)
  3. 3.3 Global Top Players by Ranibizumab Drugs and Biosimilars Price (2021-2026)
  4. 3.4 Global Ranibizumab Drugs and Biosimilars Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ranibizumab Drugs and Biosimilars Major Company Production Sites & Headquarters
  6. 3.6 Global Ranibizumab Drugs and Biosimilars Company, Product Type & Application
  7. 3.7 Global Ranibizumab Drugs and Biosimilars Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ranibizumab Drugs and Biosimilars Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ranibizumab Drugs and Biosimilars Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ranibizumab Drugs and Biosimilars Tier 1, Tier 2, and Tier 3
4 Ranibizumab Drugs and Biosimilars Regional Status and Outlook
  1. 4.1 Global Ranibizumab Drugs and Biosimilars Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ranibizumab Drugs and Biosimilars Historic Market Size by Region
  3. 4.2.1 Global Ranibizumab Drugs and Biosimilars Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ranibizumab Drugs and Biosimilars Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ranibizumab Drugs and Biosimilars Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ranibizumab Drugs and Biosimilars Forecasted Market Size by Region
  7. 4.3.1 Global Ranibizumab Drugs and Biosimilars Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ranibizumab Drugs and Biosimilars Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ranibizumab Drugs and Biosimilars Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ranibizumab Drugs and Biosimilars by Application
  1. 5.1 Ranibizumab Drugs and Biosimilars Market by Application
  2. 5.1.1 Cancer
  3. 5.1.2 Degenerative Eye Diseases
  4. 5.1.3 Other
  5. 5.2 Global Ranibizumab Drugs and Biosimilars Market Size by Application
  6. 5.2.1 Global Ranibizumab Drugs and Biosimilars Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Ranibizumab Drugs and Biosimilars Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Ranibizumab Drugs and Biosimilars Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Ranibizumab Drugs and Biosimilars Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Ranibizumab Drugs and Biosimilars Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Ranibizumab Drugs and Biosimilars Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Ranibizumab Drugs and Biosimilars Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Ranibizumab Drugs and Biosimilars Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Coherus Biosciences
  2. 6.1.1 Coherus Biosciences Company Information
  3. 6.1.2 Coherus Biosciences Business Overview
  4. 6.1.3 Coherus Biosciences Ranibizumab Drugs and Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Coherus Biosciences Ranibizumab Drugs and Biosimilars Product Portfolio
  6. 6.1.5 Coherus Biosciences Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche Ranibizumab Drugs and Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Roche Ranibizumab Drugs and Biosimilars Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 Samsung Bioepis
  14. 6.3.1 Samsung Bioepis Company Information
  15. 6.3.2 Samsung Bioepis Business Overview
  16. 6.3.3 Samsung Bioepis Ranibizumab Drugs and Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Samsung Bioepis Ranibizumab Drugs and Biosimilars Product Portfolio
  18. 6.3.5 Samsung Bioepis Recent Developments
7 North America by Country
  1. 7.1 North America Ranibizumab Drugs and Biosimilars Sales by Country
  2. 7.1.1 North America Ranibizumab Drugs and Biosimilars Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ranibizumab Drugs and Biosimilars Sales by Country (2021-2026)
  4. 7.1.3 North America Ranibizumab Drugs and Biosimilars Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ranibizumab Drugs and Biosimilars Market Size by Country
  6. 7.2.1 North America Ranibizumab Drugs and Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ranibizumab Drugs and Biosimilars Market Size by Country (2021-2026)
  8. 7.2.3 North America Ranibizumab Drugs and Biosimilars Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ranibizumab Drugs and Biosimilars Sales by Country
  2. 8.1.1 Europe Ranibizumab Drugs and Biosimilars Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ranibizumab Drugs and Biosimilars Sales by Country (2021-2026)
  4. 8.1.3 Europe Ranibizumab Drugs and Biosimilars Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ranibizumab Drugs and Biosimilars Market Size by Country
  6. 8.2.1 Europe Ranibizumab Drugs and Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ranibizumab Drugs and Biosimilars Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ranibizumab Drugs and Biosimilars Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ranibizumab Drugs and Biosimilars Sales by Country
  2. 9.1.1 Asia-Pacific Ranibizumab Drugs and Biosimilars Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ranibizumab Drugs and Biosimilars Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ranibizumab Drugs and Biosimilars Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ranibizumab Drugs and Biosimilars Market Size by Country
  6. 9.2.1 Asia-Pacific Ranibizumab Drugs and Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ranibizumab Drugs and Biosimilars Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ranibizumab Drugs and Biosimilars Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ranibizumab Drugs and Biosimilars Sales by Country
  2. 10.1.1 South America Ranibizumab Drugs and Biosimilars Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ranibizumab Drugs and Biosimilars Sales by Country (2021-2026)
  4. 10.1.3 South America Ranibizumab Drugs and Biosimilars Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ranibizumab Drugs and Biosimilars Market Size by Country
  6. 10.2.1 South America Ranibizumab Drugs and Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ranibizumab Drugs and Biosimilars Market Size by Country (2021-2026)
  8. 10.2.3 South America Ranibizumab Drugs and Biosimilars Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ranibizumab Drugs and Biosimilars Sales by Country
  2. 11.1.1 Middle East and Africa Ranibizumab Drugs and Biosimilars Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ranibizumab Drugs and Biosimilars Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ranibizumab Drugs and Biosimilars Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ranibizumab Drugs and Biosimilars Market Size by Country
  6. 11.2.1 Middle East and Africa Ranibizumab Drugs and Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ranibizumab Drugs and Biosimilars Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ranibizumab Drugs and Biosimilars Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ranibizumab Drugs and Biosimilars Value Chain Analysis
  2. 12.1.1 Ranibizumab Drugs and Biosimilars Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ranibizumab Drugs and Biosimilars Production Mode & Process
  7. 12.2 Ranibizumab Drugs and Biosimilars Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ranibizumab Drugs and Biosimilars Distributors
  10. 12.2.3 Ranibizumab Drugs and Biosimilars Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst